Showing results (2221-2230 of 3,105) with videos related to
Sort By:
Pageof 311
Expert Review of Anticancer Therapy|August 25, 2021
Cost-effectiveness of lenalidomide plus rituximab versus rituximab monotherapy in patients with previously treated follicular lymphoma: a societal viewFrederick W Thielen, Marie-José Kersten, Pim Kuizenga, et al.Expert Review of Anticancer Therapy|April 25, 2020
microRNAs as biomarkers of ovarian cancerHuilin Zhang, Bingjian LuExpert Review of Anticancer Therapy|August 18, 2025
The cost-effectiveness of toripalimab combined with chemotherapy versus chemotherapy alone in the first-line treatment of extensive-stage small cell lung cancer in China: the perspective of the medical and health system based on the EXTENTORCH studyXueying Jin, Shengkai Zhao, Zekai Zhao, et al.Expert Review of Anticancer Therapy|August 16, 2025
Genetic investigation in patients with histological variants of bladder cancer: clinical implicationsNikoo Emtiazi, Ehsan Zolfi, Farhood Khaleghi MehrExpert Review of Anticancer Therapy|August 18, 2025
Innovation in next-generation sequencing in non-small cell lung cancer diagnosticsClaudia Scimone, Lucia Palumbo, Roberto Borea, et al.Expert Review of Anticancer Therapy|August 1, 2025
Ablative radiotherapy for polymetastatic disease: a new kid on the blockFederico Camilli, Andrea Lancia, Sheetal R Kashid, et al.Expert Review of Anticancer Therapy|August 27, 2021
Antitumor effects of the multi-target tyrosine kinase inhibitor cabozantinib: a comprehensive review of the preclinical evidenceMatteo Santoni, Roberto Iacovelli, Valentina Colonna, et al.Expert Review of Anticancer Therapy|May 10, 2021
Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysisZhixian Lin, Jiangfeng Chen, Sunya HanExpert Review of Anticancer Therapy|July 19, 2025
Maintenance therapy in patients with unresectable metastatic colorectal cancer receiving oxaliplatin plus antiangiogenic-based induction regimen: a study cohorts analysisGiuseppe A Colloca, Antonella VenturinoExpert Review of Anticancer Therapy|July 9, 2025
Risk factors for secondary neoplasms in retinoblastoma survivors: a systematic literature reviewAnderson Matheus Pereira da Silva, Dillan Cunha Amaral, Luciano Falcão Carneiro Filho, et al.Pageof 311